logo-loader

Buds & Duds: Cannabis stocks cruise higher; The Green Organic Dutchman up on Health Canada approval to expand operations

TGOD received approval to expand operations into its new hybrid greenhouse in Hamilton, Ontario

Cannabis stock graphic
Also on the move were Tilray, Curaleaf, Flowr, Planet 13 and Emerald Health

Cannabis stocks had a promising start to Tuesday on the return after the long holiday weekend. 

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, nudged up 0.6% at 180.2 points. Elsewhere, the Horizons Marijuana Life Sciences Index ETF was up 0.4% at C$14.20, while the OTCQX Cannabis Index gained 2.4% at 668.9 points.

Buds

The Green Organic Dutchman Holdings Ltd (TSE:TGOD) (OTCMKTS:TGODF) shares gained ground after it said it had received approval from Health Canada to expand operations into its new hybrid greenhouse in Hamilton, Ontario. 

Shares were up 2.1% at C$3.43 in Toronto, up 3.2% at US$2.58 in New York. 

The 123,000 sq/ft facility aims to boost TGOD's premium organic cannabis production as it expands its sales in Canada.

"We are thrilled to start using this purpose-built hybrid greenhouse as we ramp up our production of premium organic cannabis, an underserved segment of the market," said CEO Brian Athaide. "Our team pioneered the concept of growing organic cannabis at scale; this hybrid greenhouse has been artfully designed for organic cultivation, allowing us to reliably produce clean, safe and non-irradiated cannabis."

READ: Green Organic Dutchman wins Health Canada approval to expand Hamilton greenhouse operations

Shares of Tilray Inc (NASDAQ:TLRY) were on the rise Tuesday, up 2.3% at US$26.27, despite reports that Cowen & Co analyst Vivien Azer has cut her price target on the stock to C$60 from C$150. Azer is also understood to have cut her price target on Cronos Group Inc (NASDAQ:CRON) to C$17 from C$21. 

Other gainers Tuesday included Curaleaf Holdings Inc (CSE:CURA) (OTCMKTS:CURLF), which unveiled its 2Q results late last week, reporting revenue of US$48.5 million, up 231% year-over-year. The firm also posted widening net losses at US$24.5 million, or US$0.05 per share, up from US$4.9 million, or US$0.01 per share in the same period a year ago. 

Shares of Curaleaf were up 9.2% at C$10.28 in Toronto, up 8.9% at US$7.69 in New York. The firm announced the opening of its 26th Florida dispensary in Port Charlotte on Tuesday.

Also gaining ground Tuesday was The Flowr Corporation (CVE:FLWR) (OTCMKTS:FLWPF), which was up 4.4% at C$3.10 in Toronto, up 4.6% at US$2.34 in New York. 

The firm recently completed the acquisition of the remaining 80.2% interest in Holigen Holdings through a share purchase agreement. The move will mean the addition of operations in Portugal and Australia to Flowr's existing Canadian platform. 

Duds

Laggards Tuesday included Planet 13 Holdings Inc (CSE:PLTH) (OTCMKTS:PLNHF), which fell 5.9% at US$1.69 in OTC trading. 

The company runs the largest cannabis dispensary in the world, hosted in Las Vegas. The firm reported second-quarter revenues of US$16.5 million on Thursday, up 275% year-over-year. The firm reported a net loss of $1.0 million in 2Q, as compared to a net loss of $6.9 million in the year-ago period. 

Emerald Health Therapeutics Inc (CVE:EMH) was also dropping Tuesday, down 4.5% at US$1.28 in New York, off 4.4% at C$1.72 in Toronto. 

The Victoria, British Columbia-based producer also reported its 2Q results late last week. Second-quarter sales came in at C$5.1 million, up 94% over the prior quarter. The firm reported a net loss of C$0.5 million. 

– Harriet Mclelland contributed to this report – 

Contact Katie Lewis at [email protected]

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of The Green Organic Dutchman Holdings Ltd named herein, including the promotion by the Company of The Green Organic Dutchman Holdings Ltd in any...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Alchemist sees big market in China for medical cannabis sales

Alchemist (CSE: AMS) CEO Paul Mann and Vice President of Business Development, Asia Pacific Johnson Lee joined Steve Darling from Proactive Vancouver to discuss Alchemist looking for opportunities for cannabis in the emerging cannabis market.  Mann and Lee talk about what the industry...

6 hours, 40 minutes ago

3 min read